Arini Syarifah Daftar Pustaka

DAFTAR PUSTAKA

  Ades T et al, 2011, Cancer Recurrence,American cancer society [AJCC ] The American Joint Committee on Cancer,2010, Seventh Edition Cancer

  Staging Manual and Handbook

  Aman U, Buzdar., S. Eva Singletary.,Vicente, Valero., Daniel, J. Booser., Nuhad, K., Ibrahim., et al, 2002, Evaluation of Paclitaxel in Adjuvant Chemotherapy for Patients with Operable Breast Cancer: Preliminary Data of a Prospective Randomized Trial Richard L. Theriault, Ronald Walters,

  Clinical Cancer Research . 8:1073-1079. ).[terhubung berkala],

  http://clincancerres.aacrjournals.org/content/8/5/1073.full.pdf+html, [8 Juli 2013]

  [ACS] American Cancer Society, 2011, Breast Cancer, Atlanta, American Cancer Society Cancer Society; 2011

  Anonim, 2011, Definition of Survival Rate, National Cancer Institute Dictionary of Cancer Terms. Anonim, 2012, Efek Samping, Jakarta, Yayasan Spiritia Aryandono, T., et al, 1997, Protokol Onkolgi RSUP Dr. Sardjito, Yogyakarta,

  Gadjah Mada University Press Bustan,M.N.2007,Epidemiologi Penyakit Tidak Menular, Jakarta, Rineka Cipta, Bontenbal ., M, Andersson., M, Wildiers., J, Cocconi., G, Jassem., J, Paridaens.,et

  al ., 1998, Doxorubicin vs epirubicin, report of a second.line randomized

  phase 11/111 study in advanced breast cancer, British Joumal of Cancer (12): 2257-2263

  Bruton, L., Lazo, J. S., Parker, K. L., 2005,

  Goodman & Gilman’s The Pharmacological Basis of Therapeutics , 11th Edition, McGrawHill,

  Lange. Chan, Stephen., Friedrichs, Kay., Noel, Daniel., Pinte´r, Tama`s., Van, Belle

  Simon., Vorobiof, Daniel., et al, 1999, Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer,

  Journal of Clinical Oncology 17: 2341-2354 Childs, AC., Phaneuf, SL., Dirks, AJ., Phillips, T., Leeuwenburgh. 2002.

  Doxorubicin treatment in vivo causes cytochromec release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and bcl-2:bax ratio.Cancer Research 62:4592-4598

  Corwin EJ, 2000, Buku Saku Patofisiologi. Pendit BU, penerjemah; Pakaryaningsing, editor. Jakarta: Penerbit Buku Kedoktoran EGC.

  Terjemahan dari: Handbook of Pathophysiology. [Depkes RI] Departemen Kesehatan Republik Indonesia, 2007, Petunjuk Teknis

  Pencegahan – Deteksi Dini Kanker Leher Rahim & Kanker Payudara.

  Jakarta,Direktorat Pengendalian Penyakit Tidak Menular, Direktorat Jendral PP & PL, Departemen Kesehatan RI. [EBCTCG]

  Early Breast Cancer Trialists’ Collaborative Group, 2005,Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials,Lancet, 365: 1687

• –1717 Ellis, IO., Schinitt, SJ., Sastre, GX., et al. 2003. Invasive Breast Carcinoma in

  World Health Organization Classification of Tumours Pathology & Genetics Tumours of the Breast and Female Genital Organs. IARC:13-59

  Fountzilas, D., Skarlos, A., Athanassiades,A., Kalogera-Fountzila, E., Samantas,C., Bacoyiannis, A., et al,1997, Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck, Annals of Oncology,8:451-455. Gabriel, N. Hortobagyi., Ames, F.C., Buzdar, A.U., Kau, S.W., Paulus, D., Hug

  V, et al, 1988, Management of Stage III Primary Breast Cancer With Primary Chemoterapy, Surgery, and Radiation Therapy. Cancer.62: 2507- 2516

  Gale, Danielle, 2000, Rencana Asuhan Keperawatan Onkologi, Jakarta, Buku Kedokteran (EGC).

  Gewirtz, D.A., 1999, A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin, Biochem. Pharmacol., 57:727-741. Groot, G., Rees, H., Pahwa, P., et al, 2011, Predicting local recurrence following breast-conserving therapy for early stage breast cancer: the significance of a narrow (</= 2 mm) surgical resection margin. Journal Surgery of Oncology. 103:212-6. Han, X., Pan, J., Ren, D., Cheng, Y., Fan, P., and Lou, H., 2008, Naringenin-7-O- glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes, Food and Chemical Toxicology , 46:3140-3146. Heidemann, E., Stoeger, H., Souchon, R., Hirschmann, WD., Bodenstein, H.,

  Oberhoff, C., et al.,2002, Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial., Annals of Oncoogyl . 13:1717-1729. Hirshaut, Yashar., Pressman, Peter I.,1992, Breast cancer : the complete guide,

  New York,Bantam Books Ismaili, Nabil., Mellas, Nawfel., Masbah.,Ouafae, Elmajjaoui, Sanaa., Arifi,

  Samia.,et al.,2009, Concurrent chemoradiotherapy in adjuvant treatment of breast cancer, Radiation Oncology BioMedCentral 04 (12).[terhubung berkala], [3 Juli 2013]

  Jolly, T., Williams, G.R., Jones E., Muss, H.B., 2012, Treatment of Metastatic Breast Cancer in Women Aged 65 Years and Older,

  Women’s Health.8

  (04):455-471 Kuraparathy, S., Reddy,K.M., Yadagiri, LA., Yutla, M., Venkata,P.B., Kadainti,

  S.V., et al, 2007, Epidemiology and a pattern of care for invasive breast carcinoma at a community hospital in southern india, world journal of

  surgical oncologi ,5:1-7 Martha, Januar Wibawa., Surianata, Sunarya., Santoso, Amiliana., 2007,Gambaran Fungsi Diastolik Ventrikel Kiri Pada Penderita Keganasan Yang Mendapat Kemoterapi Doxorubicin,

  Jurnal Kardiologi Indonesia

  (5).[terhubungberkala] r 2012]

  Manuaba, IBTW.,2010, Panduan Penatalaksanaan Kanker Payudara Peraboi

2010 . Panduan Penatalaksanaan Kanker Solid: Sagung Seto. p. 17-50.

Martin, M., Villar, A., Sole-Calvo, A., Gonzalez, R., Massuti, B., Lizon, J.,et al.,

  2003, Doxorubicin in Combination with fluorouracil and cyclophosphamide (i.v FAC regimen, day 1, 21) versus methrotrexate in combination with fluorouracil and cyclophosphamide (i.v CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group, Annals of Oncology (14):833-842 Minotti, G., Menna, P., Salvatorelli, E., Cairo,G., and Gianni, L. 2004. Anthracyclins: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity. Pharmacol Rev., 56:185-228. Mintzer, D., Glassburn, J., Mason B, A., Sataloff, D., 2002, Breast cancer in the very young patient: a multidisciplinary case presentation, The

  Oncologist .7:547-554. [terhubung berkala],

  http://www.ncbi.nlm.nih.gov/pubmed/12490742 , [9 Juli 2013] Mobus,V. J., Untch, M., du Bois, A., Lueck, H.-J. , Thomssen, C., Kuhn, W., C. et

  al. , 2004, Dose-dense sequential chemotherapy with epirubicin(E),

  paclitaxel (T) and cyclophosphamide (C) (ETC) is superior to conventional dosed chemotherapy in high- risk breast cancer patients (≥ 4

• LN). First results of an AGO-trial, Journal of Clinical Oncology.22: 513 Mobus, V., Schneeweiss, A., du Bois, A., Lueck, H-J., Eustermann, H., Kuhn, W.,

  et al ., 2012., Ten year follow-up analysis of intense dose-dense adjuvant

  ETC (epirubicin (E), paclitaxel (T) and cyclophosphamide (C)) confirms superior DFS and OS benefit in comparison to conventional dosed chemotherapy in high- risk breast cancer patients with ≥ 4 positive lymph nodes, The Journal Cancer Research: 72: 24 Naeem,M., Khan,N., Aman, Z., Nasir, A., Samad, A., Khattak, A., 2008, Pattern of breast cancer: experience at Lady Reading Hospital, Peshawar, J Ayub .20:22-25

  Med Coll Abbottabad

  [NCCN] National Comprehensive Cancer Network, 2006, NCCN Breast Cancer

  Treatment Guidelines Version VIII

  [NCCN] National Comprehensive Cancer Network, 2007, Breast Cancer

  Treatment Guidelines for Patients Version IX

  Notoatmodjo., Soekidjo, 2010, Metodologi Penelitian Kesehatan, Jakarta, Rineka Cipta

  Ogawa, Y., Nishioka, A., Inomata, T., Hamada,N., Terashima, M., Yoshida,S., et

  al ., 1994, Early experiences of breast-conservation treatment combined

  with tamoxifen and CAF chemotherapy for breast cancer of stages I and II,

NCBI. 12:29-35

  Passardi, Alessandro., Massa, Ilaria., Zoli, Wainer., Gianni, Lorenzo., Milandri, Carlo., Zumaglini, Federica., et al., 2006, Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience, BioMed Central.6:76. [terhubungberkala], http://www.biomedcentral.com/1471-2407/6/76/ , [23 Juli 2013]

  Payne, SJL., Bowen, RL., Jones, JL., Wells, CA., 2008. Predictivemarkers in breast cancer- thepresent. Histopathology; 52:82-90 Perwitasari, Dyah Aryani.,2006, Kajian penggunaan anti emetika pada pasien kanker dengan terapi sitostatika di rumah sakit di Yogyakarta, Majalah

  Farmasi Indonesia ,2:91

  Serrano, J., Palmeira, C. M., Kuehl, D. W., Wallace, K. B.,1999, Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochim. Biophys. Acta,1411, 201 –205. Siburian, Christine Handayan ., Wahyuni, Sri Eka, 2012, Dukungan Keluarga

  Dan Harga Diri Pasien Kanker Payudara Di RSUP H. Adam Malik Medan [skripsi],Medan, Fakultas Keperawatan, Universitas Sumatera

  Utara Singletary, S.E, Allred, C., Ashley, P., Bassett, L, W., Berry, D., Bland, K,I., et

  al ., 2002, Revision of the American Joint Committee on Cancer Staging

  System For Breast Cancer, Journal of Clinical Oncology.20:3628-3636 Sirait A, Oemiati R, Indrawati L. 2009. Hubungan kontrasepsi pil dengan tumor/kanker payudara di Indonesia. Majalah Kedokteran Indonesia 59

  (08). Siregar, C.J.P., 2003, Farmasi Rumah Sakit: Teori dan Penerapan, Jakarta, buku kedokteran EGC Smith L., Watson MB.

  , O’Kane SL., Drew PJ., Lind MJ., Cawkwell L.,2006,The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays,Mol. Cancer Ther. 5: 2115 – 20. Solin, LJ.,2010, Breast conservation treatment with radiation: an ongoing success story,Journal of clinical oncology,28:709 Sopiyudin,Dahlan,M.,2005,Besar Sampel untuk Penelitian Kedokteran dan

  Kesehatan ,Arkans,Jakarta

  Stephen Chan, Kay Friedrichs., Daniel Noel., Tama`s Pinte´r., Simon Van Belle., Daniel Vorobiof., et al, 1999,Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer, Journal of

  Clinical Oncology 17: 2341-2354

  Tallman,Martin, S., Gray, Robert., Robert, Nicholas J., LeMaistre, Charles F., Osborne, C. Kent M.D., William P. Vaughan, M.D., et al., 2003, Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer, The New England Journal Medicine.349:17-26).

  [terhubungberkala],http://www.nejm.org/doi/full/10.1056/NEJMoa030684 #t=articleResults, [9 Juli 2013] Tannock IF dan Hill RP. 1998, The Basic Science of Oncology, Ed ke-3.

  Singapore: McGraw-Hill. Tapan, E. 2005, Kanker, Antioksidan, dan Terapi Komplementer, Jakarta: Elex Media Komputindo. Tilanus, LMM., Alves, C., Seynaeve, C., Menke-PMB, Eggermont, AM., Brekelmans, CT., 2007, Contralateral Recurrence and Prognosis Factors in Familial Non-BRCA ½-associated Breast Cancer. Br J Surg (8):961-968

  Tjindarbumi, 1995. Diagnosis dan Pencegahan Kanker Payudara, Kursus Singkat Deteksi Dini dan Pencegahan Kanker. 6-8 November. FKC.II-POI.

  Jakarta. Vaidya, M.P., Shukla, H.S., 1983, A Textbook of Breast Cancer, New Delhi,

  Vikas Publishing House PVT LTD Van de Velve. CHJ, Bosman FT, Wagener DJTh, 1999, Onkologi. Arjono,penerjemah; Yogyakarta:Panitia Kanker RSUP DR. Sardjito. Terjemahan dari: Onkologie. Wahyuni, A.S., 2006, Hubungan Jenis Histologi dengan Ketahanan Hidup 5

  Tahun. Penderita Kanker Payudara, Majalah Kedokteran Nusantara.39:1-

  5 Wallace, Kendall B.,2003, Doxorubicin-Induced Cardiac Mitochondrionopathy,

  Basic and Clinical Pharmacology & Toxicology ,93,105-115

  [WHO] World Health Organization,2004, The Global Burden Of Disease:Update

  2004 , WHO Library Cataloguing-in-Publication Data

  Winarto, W.P., Vivi, K.T., Erna, C.F., Heri, Jumantoro., Nurrohman, Syahril., 2007, Pengobatan Herbal Untuk Kanker Payudara, Jakarta, Karyasari Herba Medika

  Wulandari, Regina., 2012, Peran Radioterapi Eksterna Adjuvan Terhadap

  Penderita Kanker Payudara Stadium Lokal-Lanjut Studi Angka Harapan Hidup Dua Tahun [karya tulis ilmiah], Semarang, Fakultas Kedokteran,

  Universitas Diponegoro Zambetti M, Bonadonna G, Valagussa P, et al, 1992, Adjuvant CMF for node- negative and estrogen receptor-negative breast cancer patients. In:

  Consensus Development Conference on the Treatment of Early-Stage Breast Cancer. Journal of the National Cancer Institute monographs (11): 77-83